Cancer Targets Missed: NHS Faces 3-Year Delay

Cancer Research UK has issued a stark warning that England's National Health Service (NHS) is significantly off track to meet its cancer treatment and diagnosis commitments. The government's National Cancer Plan, published in February of this year, set ambitious targets for March 2029, including an 80% success rate for diagnosis or all-clear within 28 days of urgent referral and an 85% rate for starting treatment within 62 days.

However, current performance indicates these goals may be missed by over three years, with the 62-day target potentially not being met until April 2032. Cancer Research UK estimates that an additional 51,000 people in England need to commence treatment on time between March of this year and March 2029 to bridge the gap. This shortfall is occurring despite projected improvements in NHS performance, highlighting a critical need for urgent action.

Michelle Mitchell, chief executive of Cancer Research UK, emphasized that "Cancer patients deserve more than ambitions." She called for an NHS equipped with the necessary staff and equipment to ensure timely diagnosis and treatment, thus offering patients the best chance of survival. The charity also noted that interim targets for 2027 and 2028 appear likely to be missed.

Separately, recent research revealed a tripling of prostate cancer rates among younger men in England over the past two decades, alongside steep increases in breast, kidney, womb, and liver cancer rates in the same age group. Experts are investigating potential links to dietary changes, antibiotic use, air pollution, and obesity. The Department of Health and Social Care maintains that the National Cancer Plan's anticipated improvements were not fully factored into the analysis and that progress is being made through new surgical hubs and diagnostic expansions.